| The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1320 | 2018 |
| Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes JJ Molenaar, J Koster, DA Zwijnenburg, P Van Sluis, LJ Valentijn, ... Nature 483 (7391), 589-593, 2012 | 949 | 2012 |
| Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations T Rausch, DTW Jones, M Zapatka, AM Stütz, T Zichner, J Weischenfeldt, ... Cell 148 (1), 59-71, 2012 | 933 | 2012 |
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 556 | 2015 |
| Neuroblastoma is composed of two super-enhancer-associated differentiation states T Van Groningen, J Koster, LJ Valentijn, DA Zwijnenburg, N Akogul, ... Nature genetics 49 (8), 1261-1266, 2017 | 441 | 2017 |
| LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression JJ Molenaar, R Domingo-Fernández, ME Ebus, S Lindner, J Koster, ... Nature genetics 44 (11), 1199-1206, 2012 | 424 | 2012 |
| TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors LJ Valentijn, J Koster, DA Zwijnenburg, NE Hasselt, P Van Sluis, ... Nature genetics 47 (12), 1411-1414, 2015 | 404 | 2015 |
| Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification LJ Valentijn, J Koster, F Haneveld, RA Aissa, P van Sluis, ... Proceedings of the National Academy of Sciences 109 (47), 19190-19195, 2012 | 247 | 2012 |
| An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity C Calandrini, F Schutgens, R Oka, T Margaritis, T Candelli, L Mathijsen, ... Nature communications 11 (1), 1310, 2020 | 227 | 2020 |
| Retinoblastoma and neuroblastoma predisposition and surveillance J Kamihara, F Bourdeaut, WD Foulkes, JJ Molenaar, YP Mossé, ... Clinical Cancer Research 23 (13), e98-e106, 2017 | 211 | 2017 |
| Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells JJ Molenaar, ME Ebus, D Geerts, J Koster, F Lamers, LJ Valentijn, ... Proceedings of the National Academy of Sciences 106 (31), 12968-12973, 2009 | 199 | 2009 |
| Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma JJ Molenaar, ME Ebus, J Koster, P Sluis, CJM van Noesel, R Versteeg, ... Cancer research 68 (8), 2599-2609, 2008 | 197 | 2008 |
| Cancer surveillance in Gorlin syndrome and rhabdoid tumor predisposition syndrome WD Foulkes, J Kamihara, DGR Evans, L Brugières, F Bourdeaut, ... Clinical Cancer Research 23 (12), e62-e67, 2017 | 180 | 2017 |
| Resection margins in oral cancer surgery: room for improvement RWH Smits, S Koljenović, JA Hardillo, I Ten Hove, CA Meeuwis, ... Head & neck 38 (S1), E2197-E2203, 2016 | 169 | 2016 |
| Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours DTW Jones, A Banito, TGP Grünewald, M Haber, N Jäger, M Kool, T Milde, ... Nature Reviews Cancer 19 (8), 420-438, 2019 | 155 | 2019 |
| The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets CM Van Tilburg, E Pfaff, KW Pajtler, KPS Langenberg, P Fiesel, BC Jones, ... Cancer discovery 11 (11), 2764-2779, 2021 | 143 | 2021 |
| The immune landscape of neuroblastoma: challenges and opportunities for novel therapeutic strategies in pediatric oncology J Wienke, MP Dierselhuis, GAM Tytgat, A Künkele, S Nierkens, ... European journal of cancer 144, 123-150, 2021 | 133 | 2021 |
| MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells JH Schulte, S Lindner, A Bohrer, J Maurer, K De Preter, S Lefever, ... Oncogene 32 (8), 1059-1065, 2013 | 123 | 2013 |
| Recommendations for childhood cancer screening and surveillance in DNA repair disorders MF Walsh, VY Chang, WK Kohlmann, HS Scott, C Cunniff, F Bourdeaut, ... Clinical Cancer Research 23 (11), e23-e31, 2017 | 115 | 2017 |
| Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe F Lamers, I Van Der Ploeg, L Schild, ME Ebus, J Koster, BR Hansen, ... Endocrine Related Cancer 18 (6), 657, 2011 | 107 | 2011 |
